Computational approaches for fragment-based and de novo design

Area of Science:

• Medicinal Chemistry
• Computational Drug Design

Background:

• Fragment-based drug discovery (FBDD) and de novo design are established computational strategies.
• These methodologies are often treated separately, despite significant overlap in their applications.

Purpose of the Study:

• To review FBDD and de novo design protocols.
• To highlight successful real-world drug discovery applications.
• To analyze the strengths, weaknesses, and complementary nature of these approaches.

Main Methods:

• Review of FBDD and de novo design protocols.
• Analysis of successful drug discovery projects.
• Discussion on integrating experimental data into computational models.

Main Results:

• Identified substantial overlap in FBDD and de novo design applications.
• Demonstrated how these methods can complement each other.
• Showcased how incorporating experimental data generates novel compounds in desired chemical property spaces and unique intellectual property (IP) areas.

Conclusions:

• Computational tools for FBDD and de novo design are impactful when integrated with appropriate experimental validation.
• Synergistic application of FBDD and de novo design, guided by experimental data, can optimize drug discovery pipelines.